- AREV NanoTech (AREV) appoints Dr. Jay Noller to its Scientific Advisory Board
- Noller is a Professor Emeritus and is the founding Director and lead researcher of Oregon State University’s (OSU) Global Hemp Innovation Center
- His experience includes more than 50 large projects, spanning much of North and South America, southern Europe, southwest Asia, and Africa
- AREV has issued 100 thousand stock options to Directors, Officers and Consultants of AREV at C$0.305 for a period of five years from the issued date
- AREV NanoTech (AREV) 21.31 per cent and is trading at C$0.37 at 11:56 am EST
AREV NanoTech (AREV) appoints Dr. Jay Noller to its Scientific Advisory Board.
Dr. Jay Noller, Ph.D., is a globally recognized polymath in agriculture, environmental and earth sciences, archaeology, and visual arts.
He has led organizations that provided diverse activities in education, research, extension, and public service relevant to seed production, soil and ecosystem services, and various natural resource management approaches.
Noller is a Professor Emeritus and is the founding Director and lead researcher of Oregon State University’s (OSU) Global Hemp Innovation Center.
The center is advancing the research of hemp and its market potential across multiple diverse industries and research fields to serve the growing international demand for innovative approaches to food, health, and fibre.
Noller has been Oregon’s leader in hemp research and policy since 2014 and has developed research partnerships with over 40 institutions globally devoted to improving hemp genetics and modes of production and processing for fibre, grain essential oils, and advances in new classes of hemp varieties.
He has directed hemp research and related industrial projects across North America, China, and Europe.
Dr. Noller is Professor Emeritus with a career of research involving soil science, geomorphology, art, and archaeology.
In addition to his hemp projects, his research principally focused on human interactions with soils in modern and ancient agricultural and forest landscapes of the Middle East, Europe and the Americas.
His experience includes more than 50 large projects, spanning much of North and South America, southern Europe, southwest Asia, and Africa.
Mike Withrow, the CEO of AREV, commented, “We are pleased to welcome Dr. Noller to the AREV Scientific Advisory Board.”
“His expertise in innovation and knowledge of human nutrition and methodology in phytomedicinal discovery will enhance our immediate corporate goals and allow significant contributions to the life science industry,” added Withrow.
“Feed the world better has been a long-held mantra of mine since I became a scholar in agriculture decades ago,” said Prof. Noller.
“I look forward to providing an advisory role to AREV NanoTec in their quests to provide for a healthier humanity through better nutritional supports, such as RUTFs,” concluded Noller.
AREV has issued 100,000 stock options to directors, officers and consultants of AREV at C$0.305 for a period of five years from the issued date.
AREV NanoTech (AREV) 21.31 per cent and is trading at C$0.37 at 11:56 am EST.
